MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,634 | -27.5% | 6,693 | -25.8% | 0.00% | – |
Q2 2023 | $11,905 | +86.7% | 9,019 | 0.0% | 0.00% | – |
Q1 2023 | $6,376 | -69.0% | 9,019 | -67.1% | 0.00% | – |
Q4 2022 | $20,587 | -84.0% | 27,449 | -81.6% | 0.00% | – |
Q3 2022 | $129,000 | +9.3% | 149,091 | +41.8% | 0.00% | – |
Q2 2022 | $118,000 | -39.5% | 105,137 | -39.5% | 0.00% | – |
Q1 2022 | $195,000 | -41.6% | 173,824 | -16.7% | 0.00% | – |
Q4 2021 | $334,000 | +554.9% | 208,668 | +887.0% | 0.00% | – |
Q3 2021 | $51,000 | -71.2% | 21,142 | -62.0% | 0.00% | – |
Q2 2021 | $177,000 | +18.8% | 55,591 | +26.1% | 0.00% | – |
Q1 2021 | $149,000 | +893.3% | 44,071 | +974.9% | 0.00% | – |
Q4 2020 | $15,000 | +7.1% | 4,100 | -24.1% | 0.00% | – |
Q3 2020 | $14,000 | +100.0% | 5,400 | +131.5% | 0.00% | – |
Q2 2020 | $7,000 | +600.0% | 2,333 | +366.6% | 0.00% | – |
Q1 2020 | $1,000 | -87.5% | 500 | -77.4% | 0.00% | – |
Q4 2019 | $8,000 | -89.9% | 2,216 | -91.6% | 0.00% | – |
Q3 2019 | $79,000 | +132.4% | 26,412 | +98.0% | 0.00% | – |
Q2 2019 | $34,000 | – | 13,342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |